Skip to main content
Veterinary Medicine International logoLink to Veterinary Medicine International
. 2026 Mar 10;2026:6649280. doi: 10.1155/vmi/6649280

A Histopathological Study of Induced Open Wounds Treated With Urinary Bladder Submucosa Scaffold in Rabbits

Majid A Alkhilani 1, Omar Tariq Hammoodi 1,✉, Ali A Tala’a 2, Waleed Al-Nuaimy 3
Editor: Sumanta Nandi
PMCID: PMC12973152  PMID: 41816198

Abstract

Treating various wounds is one of the challenges that researchers are working on to find innovative ways to shorten and accelerate healing. Various materials have been used for this purpose, including those from the submucosal layer of certain animals, such as the calf bladder used in this study. Since extracellular matrix (ECM) contains many components that are important for the healing process, such as collagen, laminin, and hyaluronic acid, it has the potential to accelerate wound healing. The study used twelve adult rabbits. After surgical preparation, a 2 × 2 cm square wound was made on each side of the animal’s body behind the costal arch in the upper abdomen. The wound on the right side was washed with normal saline only as a control group, and the wound on the left side was treated with a dry decellularized ECM. Fresh urinary bladders were collected from slaughtered calves and prepared through mechanical and chemical processes for decellularization. Excess collagenous connective and adipose tissues were removed from the bladder’s external surfaces. The submucosal layer, tunica serosa, and tunica muscular were carefully removed using a knife. The resulting sheet of submucosal bladder was then soaked in phosphate‐buffered saline (PBS) at a pH of 7.4, which contained penicillin (100 IU/mL), streptomycin (100 μg/mL), and amphotericin (100 μg/mL). The decellularized bladder matrix (UBM) was treated with a mixture of 0.1% peracetic acid (PAA) and 4% ethanol, shaking the solution for 2 h at room temperature. The wound was covered with a sterile gauze until the seventh postwounding day (PWD), when the wound was measured, and samples were collected for histopathological examination. Additional samples were collected for histopathological examination at the 14th and 21st PWDs. Visual inspection, wound size measurement, and histopathological examination of both groups revealed that the ECM scaffold had a significant effect on accelerating healing compared with the control group starting from the seventh PWD. The percentage of wound contraction was clearly in favor of the treatment group compared to that of the control group. At the end of the experiment, the epidermal layer and rete ridge were completely thick, with fibroplasia of the dermal layer in the treated group, while in the control group, there was fibrosis in the subcutaneous tissue, and granulation tissue consisting of blood vessels, fibroblasts, and collagen fibers infiltrated with mononuclear cells, but there was no rete bridge. In conclusion, the use of ECM scaffolds plays an important role in accelerating wound healing, making its use advantageous in open wounds.

Keywords: accelerate wound healing, extracellular matrix, natural scaffold, urinary bladder submucosa

1. Introduction

The skin has many more functions besides basic mechanical protection; it is central to fluid and heat exchange with the environment [1, 2]. A series of interactions occur in response to skin injury, but the main stages are hemostasis, inflammation, formation of new tissue, and remodeling [3]. Migration of polymorphonuclear leukocytes to the wound and macrophages follows to engulf and destroy microbes and necrotic debris and plays an influential role in the healing process of the wound through releasing proteases that decompose damaged extracellular matrix (ECM) and in tissue cytokines [4]. The fibrin matrix and necrotic tissue begin to be replaced by fibroblasts with ECM, which initiates granulation tissue formation, maturation of ECM due to the remodeling phase, including the ECM remodeling into normal skin architecture, and differentiation of some fibroblasts into contractile myofibroblasts, which share in wound contraction [5]. Also, control of infection and inflammation is important to successful wound healing. ECM is composed of many ingredients such as collagen, hyaluronic acid, and laminin. Cells in tissue secrete ECM; these ingredients are arranged in specific tissue patterns, in which collagen is widely used for coating materials and skin tissue engineering. ECM is one of the promising biomaterials for varied applications [6].

Fibroblasts are the dominant cell during the proliferation phase of wound healing. Fibroblasts are critical components of granulation tissue and achieve variant functions, including the manufacture of collagen, elastin, fibronectin, glycosaminoglycan, and proteases. Also, the production of the ECM acts for further critical functions; it promotes the adherence of the cells, significantly manages, and arranges the growth of the cells inside it [7, 8]. Mature fibroblasts are decreased at the last section of this phase and replaced by myofibroblasts [9].

The final phase of the proliferation stage involves enhancing the dense granulation tissue, while the remodeling process has already commenced. This intermediate tissue acts as a substitute for the fibrin and fibronectin‐based temporary wound matrix, which can eventually lead to scar formation through maturation [10, 11]. During the proliferation phase, typically spanning from the 3rd to 10th postwounding day (PWD), the primary goal of the healing process is to protect the surface of the wound, producing granulation tissue and restoring the vascular complex. This is accompanied by the migration of local fibroblasts through the fibrin mesh and the initiation of re‐epithelialization at the wound edges, while neovascularization and angiogenesis begin to occur [12, 13].

Collagen is secreted to the extracellular space in the form of precollagen, which is then transformed into collagen fibrils, which aggregate to form collagen fibers. Elastin is also present in the wound in smaller amounts [14]. The repaired tissue becomes further fibrous through the replacement of Type III collagen by Type I collagen. Then, the collagen fibers are arranged longitudinally in the repaired site; by this means, restoring tensile strength, as well as decreasing the process of angiogenesis, the blood flow descends, and the activity of the acute metabolic rate of the wound slows and eventually stops [15–17].

Many studies on different therapeutic materials have been used to improve and enhance wound healing and maintain internal homeostasis. New techniques, measures, and products were used, including medical dressing and therapy to accelerate the healing of treated wounds [18, 19].

This study aims to evaluate the efficacy of a urinary bladder submucosa scaffold on the healing of experimentally induced open wounds in rabbits.

2. Materials and Methods

2.1. Ethical Approval

The local committee of animal care at the University of Fallujah was granted ethical approval before starting the study (Number 31 on 21/5/2024).

2.2. Materials and Surgical Procedure

Twelve adult (9–12 months), local breeds of both sex rabbits (4 females and 8 males), weighing 1.5–2 kg, were included in this research. All rabbits were housed in the animal house of the College of Veterinary Medicine, Al Fallujah University. They were fed green and concentrated food and examined physically to determine that they were healthy. The skin was prepared surgically with an aseptic routine technique, and square full‐thickness skin wounds (2 × 2 cm) were made on all animals in both lateral abdominal regions behind the coastal arch under general anesthesia by using a combination of ketamine (35 mg/kg B.W and xylazine 5 mg/kg B.W, I/M) [20]. The left wounds were treated with decellularized extracellular matrix (DECM) scaffold as a layer covering entire wounds, and the right wounds were not treated and left as control (Figure 1). The wounds were dressed with sterile bandage to prevent any contamination until the specimens were taken for measurement of wound size and for histopathological study on the 7th, 14th, and 21st PWD; no antibiotics was administered postwounding to all animals in both groups. Specimens of skin were collected on the 7th, 14th, and 21st PWD, conserved in formaldehyde, and they were prepared in the usual manner for the purpose of histopathological study, sectioned in 6 μ, and stained with H&E [21] in the College of Veterinary Medicine, University of Baghdad.

FIGURE 1.

FIGURE 1

The left induced incision was covered with DSMS, and the right was washed with normal saline.

2.3. Preparation of Urinary Bladder Submucosal Scaffold

The decellularized urinary bladder scaffold was prepared following the protocol outlined in references [19, 22, 23]. Fresh urinary bladders were collected from calves at a local abattoir and underwent mechanical and chemical processes for decellularization. Excess collagenous connective tissues and adipose tissue were removed from the bladder’s external surfaces using scissors. The bladder was then bisected to create a rectangular sheet from its opening to the apical region. The submucosal layer, tunica serosa, and tunica muscularis were carefully excised using a knife. The resulting flattened rectangular sheet of the bladder (submucosal layer) was soaked in phosphate‐buffered saline (PBS) at a pH of 7.4, which contained penicillin (100 IU/mL), streptomycin (100 μg/mL), and amphotericin (100 μg/mL). Following this, the decellularized urinary bladder matrix (UBM) was treated with a mixture of 0.1% peracetic acid (PAA) and 4% ethanol, shaking the solution for 2 hours at room temperature to minimize the risk of host rejection. The ECM was then rinsed with PBS and shaken for 15 min at room temperature. It was subsequently rinsed in water twice, again shaken for 15 min at room temperature, and finally rinsed with PBS once more. The resulting decellularized ECM scaffolds were sterilized by immersion in a 0.1% PAA solution titrated to pH 7.0 at room temperature for 5 h. The scaffolds were preserved in sterile PBS containing antibiotics and antifungal agents and then stored at 4°C. The decellularized UBM sheets were allowed to set slightly before being transferred to −20°C for 24 h, followed by storage in a deep freezer at −80°C for 5 days. Subsequently, the scaffolds were freeze‐dried for 4 days at −50°C. After freeze‐drying, the decellularized material was thawed at room temperature and lyophilized before being milled into a fine powder. The powder was sterilized by heating it in an oven at 60°C for 16 h and later stored in a sterile container.

The wound’s length and width are measured by a Vernier caliper, and the percent wound contraction is calculated by the following equation [24]:

percent total wound contraction=wound area of day Noriginal wound area of day 0∗100%. (1)

2.4. Statistical Analysis

Two‐way analysis of variance (ANOVA) using the standard least‐squares procedure of JMP Pro 16.00 software (SAS, Institute Inc., Cary, NC, USA) was used to analyze the wound contraction rate. Fisher’s least significant difference (LSD) post hoc test was used to determine the differences between treatment or time at p ≤ 0.05.

3. Results

All animals tolerated the surgical procedures well, and none of the experimental animals developed outward signs of systemic infection at the surgical site at any time postoperatively.

3.1. Macroscopic Findings

On the seventh PWD, wound contraction occurred in both groups compared to the first wounding day, with the presence of a scab covering the wound, noting that wound size was significantly reduced in the treated group with DSMS (Figures 2 and 3). The difference in wound size was clearer at the 14th PWD when comparing the two groups (Figures 4 and 5). At the 21st PWD, full epithelialization was observed in the treated group, but in the control group, there was still a scab (Figures 6 and 7), approximately the size of the scab in the treated group at the 14th PWD.

FIGURE 2.

FIGURE 2

Wound of the control group on the 7th PWD.

FIGURE 3.

FIGURE 3

Wound of the treatment group on the 7th PWD.

FIGURE 4.

FIGURE 4

Wound of the control group on the 14th PWD.

FIGURE 5.

FIGURE 5

Wound of the treatment group on the 14th PWD.

FIGURE 6.

FIGURE 6

Wound of the control group on the 21st PWD.

FIGURE 7.

FIGURE 7

Wound of the treatment group on the 21st PWD.

The wound contraction percentage calculated according to the equation of [24] showed that the percentage of wound contraction was clearly in favor of the treatment group compared to that of the control group (Table 1); this was a result of calculating the percentage based on the wound contraction of the wound measurements, as shown in Table 2, which demonstrates the mean value of the wound size in centimeters for all periods in both groups. The mean value for the treated group was 2.4 and 0.37 cm, and the scar formation was at the 7th, 14th, and 21st PWD, while in the control group, the mean value was 2.8, 1.3, and 0.06 cm at the 7th, 14th, and 21st PWD, respectively.

TABLE 1.

Percentage (%) of wound contraction.

Animals Treatment group Mean Control group Mean
1st subgroup 2nd subgroup 3rd subgroup 4th subgroup 1st subgroup 2nd subgroup 3rd subgroup 4th subgroup
Postwound day
7th 30% 25% 30% 20% 26.25 15% 10% 12.5% 10% 11.875
14th 75% 70% 72% 65% 70.5 40% 45% 57% 52% 48.5
21st 100 100 100 100 100 90% 85% 80% 90% 86.25

TABLE 2.

Measurement of the wound size by centimeters.

Animals postwound day Treatment group (cm2) Mean Control group (cm2) Mean
Zero day 1st subgroup 2nd subgroup 3rd subgroup 4th​ sub group 1st subgroup 2nd subgroup 3rd subgroup 4th subgroup
7th 4 2.24 2.55 2.55 2.4 2.4 2.85 2.5 3 2.88 2.8
14th 4 0.35 0.24 0.4 0.49 0.37 1.43 1.68 1.2 0.9 1.3
21st 4 scar scar scar scar — 0.03 0.02 0.08 0.12 0.06

The statistical study showed that the treatment group was superior in wound healing speed throughout the study periods, and wound contraction was significant at p < 0.05 (Table 3) and​ (Figure 8).

TABLE 3.

Effect of urinary bladder submucosa scaffold on wound contraction rate (%).

Time (days) Treatment Main effect Time p value (LSD)
Control Scaffold
7 11.9 ± 1.20f 26.2 ± 2.39e 19.1 ± 2.99Z < 0.001 (4.805)
14 48.5 ± 3.75d 70.5 ± 2.10c 59.5 ± 4.61Y  
21 86.2 ± 2.39b 100 ± 0.00a 93.1 ± 2.82X  
Main effect treatment 48.9 ± 9.26B 65.6 ± 9.19A    
  p value (LSD) < 0.001 (3.924)    
Treatment × time        
  p value (LSD) < 0.001 (6.796)    

Note: n = 4 per treatment group. Values are means ± SEM, a–f Means followed by different lowercase letters in the same column or row are different from each other in the interaction effect Treatment × time. A‐B Means followed by different uppercase letters in the same column differ in the treatment factor. X‐z Means followed by different uppercase letters in the same column are different in the time factor.

FIGURE 8.

Effect of factors: (a) time (including the control group and urinary bladder submucosa scaffold group, (b) treatment (including all times), and (c) treatment (including both treatment and times). Values are means ± SEM, n = 4.

graphic file with name VMI-2026-6649280-g008.jpg

(a)

graphic file with name VMI-2026-6649280-g009.jpg

(b)

graphic file with name VMI-2026-6649280-g015.jpg

(c)

3.2. Histopathological Findings

On the 7th PWD, the histopathological picture of the treated group showed a vacuolated thick epidermal layer with the presence of a rete ridge (RR) over the dermal layer, which was infiltrated with mononuclear cells and neovascularization with a high number of fibroblasts (Figures 9 and 10).

FIGURE 9.

FIGURE 9

Histopathological section of the treated group on the 7th post‐wounding day shows a vacuolated epidermal layer Inline graphic and a high number of inflammatory cells Inline graphic and neovascularization (red arrows) (H&E stain 400 X).

FIGURE 10.

FIGURE 10

Histopathological section of the treated group on the 7th postwounding​ day shows thick rete ridge Inline graphic and edema in the subepidermal layer in addition to inflammatory cell aggregation in the dermal layer Inline graphic with a high number of fibroblasts (red arrows) (H&E stain 400 ×).

In the control group, at the same time, the histopathological finding showed a vacuolated epidermal layer, but less than in the treated group on the same day, and vascular granulation tissue in the dermis infiltrated with denser infiltration of inflammatory cells, and no RRs were found with a high concentration of inflammatory cells, and neovascularization (Figure 11).

FIGURE 11.

FIGURE 11

Histopathological section of the control group on the 7th postwounding day shows vacuolation of the epidermal layer Inline graphic over vascular granulation tissue in the dermis with a high number of inflammatory cells Inline graphic and neovascularization (red arrows) (H&E stain 400 ×).

On the 14th PWD in the treated group, there was the complete thickness of the epidermal layer, and RR, with fibroplasia of the dermal layer, and collagen fibers appeared in some areas dense and regular, and fibroblast cells (Figures 12 and 13). While in the control group on the 14th PWD, there was fibrosis in the subcutaneous tissue, and granulation tissue consisting of blood vessels, fibroblasts, and collagen fibers appeared irregular and not arranged in parallel, infiltrated with mononuclear cells, but there was no RR (Figures 14, 15 and 16).

FIGURE 12.

FIGURE 12

Histopathological section of the treated group on the 14th postwounding day shows a complete thickness epidermal layer Inline graphic with cellular rete ridge Inline graphic under epidermal layer, and over fibroplasia of dermal layer, collagen fibers appear in some areas dense and regular and fibroblast cells Inline graphic (H&E stain 100 ×).

FIGURE 13.

FIGURE 13

Histopathological section of the treated group on the 14th postwounding day shows a complete thickness epidermal layer Inline graphic with rete ridge over fibroplasia of the dermal layer infiltrated with a few mononuclear cells Inline graphic (H&E stain 400 ×).

FIGURE 14.

FIGURE 14

Histopathological section of the control group on the 14th postwounding day shows fibrosis with collagen fibers that were dense, thick, and better arranged around the incision gap in S/C tissue Inline graphic infiltrated by mononuclear cells Inline graphic (H&E stain 100 ×).

FIGURE 15.

FIGURE 15

Histopathological section of the control group on the 14th postwounding day shows collagen fibers developed and well arranged in the epidermal layer Inline graphic over vascular granulation tissue consisting of blood vessels, fibroblasts, and fewer inflammatory cells Inline graphic (H&E stain 100 ×).

FIGURE 16.

FIGURE 16

Histopathological section of the control group on the 14th postwounding day shows vacuolation of the epidermal layer Inline graphic over vascular granulation tissue in the dermis infiltrated by inflammatory cells Inline graphic (H&E stain 400 ×).

On the 21st PWD in the treated group, the epidermal layer thickness was complete with a RR and a keratinized layer with sebaceous in the dermal layer; the collagen fibers appear more regular and are arranged in parallel (Figure 17).

FIGURE 17.

FIGURE 17

Histopathological section of the treated group on the 21st postwounding day shows a complete thickness epidermal layer with rete ridge Inline graphic, keratinized layer, and collagen fibers that were dense, thick, and better arranged at this stage Inline graphic (H&E stain 100 ×).

In the control group on the 21st PWD, vascular granulation tissue appeared to consist of blood vessels, fibroblasts, and collagen fibers infiltrated with mononuclear cells and collagen fiber that till now more of them appear irregular and less dense (Figure 18). The collagen fibers were present in both groups at this time but they were more regular and mature in the treatment group.

FIGURE 18.

FIGURE 18

Histopathological section of the control group on the 21st postwounding day shows that collagen fibers were dense and well developed Inline graphic, and scattered inflammatory cells Inline graphic are attached to the muscle layer Inline graphic (H&E stain 100 ×).

4. Discussion

The wound size began to contract gradually through the days of experiments as an indicator of the healing process development, but it was better in the treated group as a result of the ECM used. This agrees with many researchers, including [9], who noticed that the wound contraction in the treated group with methionine was faster and earlier than in the control group, which began on the 7th PWD. Likewise, the researchers [25] saw that the size of the wound decreased significantly on the 14th PWD to more than 50% compared to the size of the wound on zero PWD.

Skin tissue regeneration is a significant clinical challenge because of the various cell types and the complex structure of the skin. Traditional methods, such as cell transplantation and growth factor treatments, frequently fail due to the adverse conditions present at the wound site [26].

The epidermal layer in the treatment group appeared thicker when compared to that in the control group from the 7th PWD, and its thickness was complete on the 14th PWD in the treatment group compared to that in the control group. The fibroblasts appeared on day 7 as part of the natural wound healing process, producing collagen fibers, which was clearly present on the 14th day PWD in both groups; it was more regular with a wavey shape in the treatment group, but it was not so in the control group, in which the presence of granulation tissue persisted with a dense presence of inflammatory cells on the 14th PWD. This agrees with Al‐Mutheffer et al. [27], who noticed that the epithelial layer reached full thickness on the 14th PWD in the treatment group, compared to that in the control group, which showed granulation tissue and blood vessels at the same time. Weller et al. [28] showed that fibroblasts experienced phenotypic changes and transformed into myofibroblasts, establishing strong adhesions with the surrounding granulation tissue and supplying the force necessary for wound contraction.

Certain areas of the epidermis extend into the dermis, creating a wavy formation known as the RR. The dermis, as the most resilient fibrous layer of the skin, is primarily composed of collagen fibers, fibroblasts, blood vessels, nerves, and immune cells [28]. RRs are important microstructures at the dermis–epidermis junction in the skin, crucial for enhancing skin mechanics and homeostasis. In tissue engineering and regenerative medicine, while artificial skin grafts have advanced, the restoration of RRs is often overlooked, possibly affecting the effectiveness of skin healing and regeneration [29]. In this study, the RRs were seen in the treatment group from the 7th PWD but were not present in the control group on the 7th and 14th PWD or even the 21st PWD, which explains the healing process that agrees with [30, 31] as the morphology of RRs is a key characteristic of both intact and regenerated human skin, and the depth and structure of RRs serve as indicators of the effectiveness of wound healing [32].

The clear, dense collagen fibers on the 14th PWD and mature and regular on the 21st PWD in the treatment group in this study were indicated to advance in wound healing as [33] who found that the active components within different substances were used to enhance the wound healing process by improving the durability of collagen fibrils, strengthening collagen fibers through increased circulation, and preventing cell damage. The authors [34] explain that collagen often accumulates during the final phase of wound healing, and the collagen fibers were visible on either side of the wound; then, they spread to the center, and ultimately, they were organized uniformly throughout the whole dermis. Furthermore, the regeneration of skin, collagen, and blood vessels increased in the treatment group, which is consistent with [35].

The scaffolds ought to permit the transport of the supplements required for the cell connection, multiplication, and differentiation; incitement of cell–biomaterial connection, development, and relocation; and a controlled debasement rate with no harmfulness or aggravation hazard to the cells [36]; therefore, the results of this study showed a clear advantage for wound healing in the group treated with scaffold when compared to that in the control group through the advanced healing stages since the 7th PWD, and this indicates a clear effect of ECM in wound healing in a shorter period. This ECM attracts the inflammatory cells like neutrophils, lymphocytes, and macrophages, which infiltrate the defect. The neutrophils were the main cells in an acute inflammatory stage, which play an important role in phagocytosis. Also, the infiltrated macrophages play an important role in delivering growth factors and cytokines to facilitate the conversion to the proliferative stage, which agrees with Al‐Mutheffer et al. [27] who proved that the use of some treatments like DL‐methionine, which was used in their study, accelerates the maturation and remodeling process, which should actually begin when the connective tissue matures and the granulation tissue turns into a scar, and [25] noticed that after 14 days of infection, the treated wounds with blue led light have a higher degree of epithelialization.

Our study agreed with Alkhilani et al. [19] who found that at day 21st PWD, healing was evident in the treated groups, with good epithelialization associated with newly produced mature collagen fibers and angiogenesis, while the control group still had poor epithelialization with inflammatory cells and mild angiogenesis. The occurrence of advanced healing in these groups is due to the presence of the ECM scaffold, which provides a fundamental part of repair and healing.

5. Conclusion

The healing time in the treatment group was earlier and clearer on the 7th PWD, which indicates a good effect of the ECM scaffold on accelerating healing. The use of an ECM scaffold, which is a natural substance, in the treatment of open wounds was effective in the rate of wound healing and contraction.

Funding

No funding was received for this manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.

Acknowledgments

I would like to express my thanks to the College of Veterinary Medicine, University of Fallujah, for supporting the present work and the laboratory facilities.

Alkhilani, Majid A. , Hammoodi, Omar Tariq , Tala’a, Ali A. , Al‐Nuaimy, Waleed , A Histopathological Study of Induced Open Wounds Treated With Urinary Bladder Submucosa Scaffold in Rabbits, Veterinary Medicine International, 2026, 6649280, 9 pages, 2026. 10.1155/vmi/6649280

Academic Editor: Sumanta Nandi

Contributor Information

Omar Tariq Hammoodi, Email: omar.hammoodi@gmail.com.

Sumanta Nandi, Email: lbuch@wiley.com.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1. Amarah A. A., Petlin D. G., Grice J. E., Hadgraft J., Roberts M. S., and Anissimov Y. G., Compartmental Modeling of Skin Transport, European Journal of Pharmaceutics and Biopharmaceutics. (September 2018) 130, 336–344, 10.1016/j.ejpb.2018.07.015, 2-s2.0-85050341594. [DOI] [PubMed] [Google Scholar]
  • 2. Jobanputra R. D., Boyle C. J., Dini D., and Masen M. A., Modelling the Effects of Age-Related Morphological and Mechanical Skin Changes on the Stimulation of Tactile Mechanoreceptors, Journal of the Mechanical Behavior of Biomedical Materials. (December 2020) 112, 10.1016/j.jmbbm.2020.104073. [DOI] [PubMed] [Google Scholar]
  • 3. Eming S. A., Martin P., and Tomic-Canic M., Wound Repair and Regeneration: Mechanisms, Signaling, and Translation, Science Translational Medicine. (December 2014) 6, no. 265, 10.1126/scitranslmed.3009337, 2-s2.0-84915789422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Delavary B. M., van der Veer W. M., van Egmond M., Niessen F. B., and Beelen R. H., Macrophages in Skin Injury and Repair, Immunobiology. (July 2011) 216, no. 7, 753–762, 10.1016/j.imbio.2011.01.001, 2-s2.0-79957598147. [DOI] [PubMed] [Google Scholar]
  • 5. Turner N. J. and Badylak S. F., The Use of Biologic Scaffolds in the Treatment of Chronic Nonhealing Wounds, Advances in Wound Care. (August 2015) 4, no. 8, 490–500, 10.1089/wound.2014.0604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Hammoodi O. T. and Salih S. I., Efficacy of Tendon Derived Hydrogel and Hyaluronic Acid in Repair of Experimentally Induced Superficial Digital Flexor Tendon Defect in Rams, Biochemical and Cellular Archives. (April 2020) 20, no. 1, 10.35124/bca.2020.20.1.1591. [DOI] [Google Scholar]
  • 7. Eckes B., Nischt R., and Krieg T., Cell-Matrix Interactions in Dermal Repair and Scarring, Fibrogenesis & Tissue Repair. (December 2010) 3, 4–1, 10.1186/1755-1536-3-4, 2-s2.0-77955775124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Barker T. H., The Role of ECM Proteins and Protein Fragments in Guiding Cell Behavior in Regenerative Medicine, Biomaterials. (June 2011) 32, no. 18, 4211–4214, 10.1016/j.biomaterials.2011.02.027, 2-s2.0-79955120631. [DOI] [PubMed] [Google Scholar]
  • 9. Hinz B., Masters and Servants of the Force: The Role of Matrix Adhesions in Myofibroblast Force Perception and Transmission, European Journal of Cell Biology. (April 2006) 85, no. 3-4, 175–181, 10.1016/j.ejcb.2005.09.004, 2-s2.0-33644948094. [DOI] [PubMed] [Google Scholar]
  • 10. Krafts K. P., Tissue Repair: the Hidden Drama, Organogenesis. (October 2010) 6, no. 4, 225–233, 10.4161/org.6.4.12555, 2-s2.0-77956404516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Nauta A., Gurtner G. C., and Longaker M. T., Wound Healing and Regenerative Strategies, Oral Diseases. (September 2011) 17, no. 6, 541–549, 10.1111/j.1601-0825.2011.01787.x, 2-s2.0-79960677445. [DOI] [PubMed] [Google Scholar]
  • 12. Singh S., Young A., and Mc Naught C. E., The Physiology of Wound Healing, Surgery. (September 2017) 35, no. 9, 473–477, 10.1016/j.mpsur.2017.06.004, 2-s2.0-85026242858. [DOI] [Google Scholar]
  • 13. Bauer S. M., Bauer R. J., and Velazquez O. C., Angiogenesis, Vasculogenesis, and Induction of Healing in Chronic Wounds, Vascular and Endovascular Surgery. (July 2005) 39, no. 4, 293–306, 10.1177/153857440503900401, 2-s2.0-23044438985. [DOI] [PubMed] [Google Scholar]
  • 14. Xue M. and Jackson C. J., Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring, Advances in Wound Care. (March 2015) 4, no. 3, 119–136, 10.1089/wound.2013.0485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Reinke J. M. and Sorg H., Wound Repair and Regeneration, European Surgical Research. (July 2012) 49, no. 1, 35–43, 10.1159/000339613, 2-s2.0-84863748841. [DOI] [PubMed] [Google Scholar]
  • 16. Demaria M., Stanley B. J., Hauptman J. G. et al., Effects of Negative Pressure Wound Therapy on Healing of Open Wounds in Dogs, Veterinary Surgery. (August 2011) 40, no. 6, 658–669, 10.1111/j.1532-950X.2011.00849.x, 2-s2.0-79961024356. [DOI] [PubMed] [Google Scholar]
  • 17. Hadley H. S., Stanley B. J., Fritz M. C., Hauptman J. G., and Steficek B. A., Effects of a Cross‐Linked Hyaluronic Acid Based Gel on the Healing of Open Wounds in Dogs, Veterinary Surgery. (February 2013) 42, no. 2, 161–169, 10.1111/j.1532-950X.2012.01048.x, 2-s2.0-84873480117. [DOI] [PubMed] [Google Scholar]
  • 18. Pitt K. A. and Stanley B. J., Negative Pressure Wound Therapy: Experience in 45 Dogs, Veterinary Surgery. (May 2014) 43, no. 4, 380–387, 10.1111/j.1532-950X.2014.12155.x, 2-s2.0-84899992353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Alkhilani M. A., Hammoodi O. T., Emran H. A., and Alhayani W. A., Impact of Using Processed Urinary Bladder Submucosa and Hydrogel Fabricated From Tendon on Skin Healing Process in Rabbits, Veterinary Medicine International. (2024) 2024, no. 1, 10.1155/2024/6641975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Oguntoye C. O. and Oke B. O., A Comparison of Xylazine/Ketamine, Diazepam/Ketamine and Acepromazine/Ketamine Anaesthesia in Rabbit, Sokoto Journal of Veterinary Sciences. (2014) 12, no. 3, 21–25, 10.4314/sokjvs.v12i3.4. [DOI] [Google Scholar]
  • 21. Suvarna S. K., Layton C., and Bancroft J. D., Theory and Practice of Histological Techniques Eighth, 2019, Elsevier Health Sci. [Google Scholar]
  • 22. Al-Ameri S. H. and Al-Timmemi H. A., The Effectiveness of Extracellular Matrix Derived From Bovine Urinary Bladder Matrix on Spinal Cord Injury in Dog, IJONS. (2018) 9, no. 50, 976–979. [Google Scholar]
  • 23. Rosario D. J., Reilly G. C., Ali Salah E., Glover M., Bullock A. J., and MacNeil S., Decellularization and Sterilization of Porcine Urinary Bladder Matrix for Tissue Engineering in the Lower Urinary Tract, Regenerative Medicine. (March 2008) 3, no. 2, 145–156, 10.2217/17460751.3.2.145, 2-s2.0-42249104019. [DOI] [PubMed] [Google Scholar]
  • 24. Bohling M. W., Henderson R. A., Swaim S. F., Kincaid S. A., and Wright J. C., Cutaneous Wound Healing in the Cat: A Macroscopic Description and Comparison With Cutaneous Wound Healing in the Dog, Veterinary Surgery. (November 2004) 33, no. 6, 579–587, 10.1111/j.1532-950X.2004.04081.x, 2-s2.0-13744251829. [DOI] [PubMed] [Google Scholar]
  • 25. Jabbar L. M. and Abid T. A., Treatment of Infected Wounds by Using Antimicrobial Blue Light Phototherapy, Iraqi Journal of Veterinary Sciences. (April 2024) 38, no. 2, 259–266, 10.33899/ijvs.2023.141837.3140. [DOI] [Google Scholar]
  • 26. Choudhury S. and Das A., Advances in Generation of Three-Dimensional Skin Equivalents: Pre-Clinical Studies to Clinical Therapies, Cytotherapy. (January 2021) 23, no. 1, 1–9, 10.1016/j.jcyt.2020.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Al-Mutheffer E. A., Omar R. A., and Ali A. F., Local Application Benefits of DL-Methionine as Wound Powder: A Novel Approach for Wound Healing Process in Rabbits, Iraqi Journal of Veterinary Sciences. (2024) 38, no. 3, 523–529, 10.33899/ijvs.2024.143690.3267. [DOI] [Google Scholar]
  • 28. Weller R. B., Hunter H. J., and Mann M. W., Clinical Dermatology, 2015, John Wiley & Sons. [Google Scholar]
  • 29. Shen Z., Sun L., Liu Z. et al., Rete Ridges: Morphogenesis, Function, Regulation, and Reconstruction, Acta Biomaterialia. (January 2023) 155, 19–34, 10.1016/j.actbio.2022.11.031. [DOI] [PubMed] [Google Scholar]
  • 30. Salter S. A. and Kimball A. B., Striae Gravidarum, Clinics in Dermatology. (March 2006) 24, no. 2, 97–100, 10.1016/j.clindermatol.2005.10.008, 2-s2.0-32644448199. [DOI] [PubMed] [Google Scholar]
  • 31. Rai A., Ahmad T., Parveen S., Parveen S., Faizan M. I., and Ali S., Expression of Transforming Growth Factor Beta in Oral Submucous Fibrosis, Journal of Oral Biology and Craniofacial Research. (April 2020) 10, no. 2, 166–170, 10.1016/j.jobcr.2020.03.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Wong V. W., Longaker M. T., and Gurtner G. C., Soft Tissue Mechanotransduction in Wound Healing and Fibrosis, Seminars in Cell & Developmental Biology. (December 2012) 23, no. 9, Academic Press, 981–986, 10.1016/j.semcdb.2012.09.010, 2-s2.0-84870551751. [DOI] [PubMed] [Google Scholar]
  • 33. Thakur R., Jain N., Pathak R., and Sandhu S. S., Practices in Wound Healing Studies of Plants, Evidence-Based Complementary and Alternative Medicine. (2011) 2011, no. 1, 10.1155/2011/438056, 2-s2.0-80052776616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Feng X., Zhang X., Li S. et al., Preparation of Aminated Fish Scale Collagen and Oxidized Sodium Alginate Hybrid Hydrogel for Enhanced Full-Thickness Wound Healing, International Journal of Biological Macromolecules. (December 2020) 164, 626–637, 10.1016/j.ijbiomac.2020.07.058. [DOI] [PubMed] [Google Scholar]
  • 35. Rashtbar M., Hadjati J., Ai J. et al., Critical‐Sized Full‐Thickness Skin Defect Regeneration Using Ovine Small Intestinal Submucosa With or Without Mesenchymal Stem Cells in Rat Model, Journal of Biomedical Materials Research Part B: Applied Biomaterials. (2018) 106, no. 6, 2177–2190, 10.1002/jbm.b.34019, 2-s2.0-85052601167. [DOI] [PubMed] [Google Scholar]
  • 36. Thorrez L., Shansky J., Wang L. et al., Growth, Differentiation, Transplantation and Survival of Human Skeletal Myofibers on Biodegradable Scaffolds, Biomaterials. (January 2008) 29, no. 1, 75–84, 10.1016/j.biomaterials.2007.09.014, 2-s2.0-35348998576. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Veterinary Medicine International are provided here courtesy of Wiley

RESOURCES